Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy

Oncolytic viruses (OVs) are an emerging class of therapeutics which combine multiple mechanisms of action, including direct cancer cell-killing, immunotherapy and gene therapy. A growing number of clinical trials have indicated that OVs have an excellent safety profile and provide some degree of eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Reale, Alberto, Calistri, Arianna, Altomonte, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709025/
https://www.ncbi.nlm.nih.gov/pubmed/34959474
http://dx.doi.org/10.3390/pharmaceutics13122192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709025/
https://www.ncbi.nlm.nih.gov/pubmed/34959474
http://dx.doi.org/10.3390/pharmaceutics13122192

Ejemplares similares